User profiles for JEAN-NOËL TALBOT

Jean-Noël Talbot

Prof de Médecine Nucléaire, Université P&M Curie, Hopital Tenon, Paris, FRANCE
Verified email at tnn.aphp.fr
Cited by 6725

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis

…, A Luciani, J Dupuis, G Paone, JN Talbot… - Journal of Nuclear …, 2007 - Soc Nuclear Med
The purpose of this study was to assess the prognostic value of early 18 F-FDG PET using
standardized uptake value (SUV) compared with visual analysis in patients with diffuse large B…

[HTML][HTML] The EANM practice guidelines for parathyroid imaging

…, M Luster, A Piccardo, T Weber, JN Talbot… - European journal of …, 2021 - Springer
Introduction Nuclear medicine parathyroid imaging is important in the identification of
hyperfunctioning parathyroid glands in primary hyperparathyroidism (pHPT), but it may be also …

Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease

JN Talbot, L Fartoux, S Balogova, V Nataf… - Journal of Nuclear …, 2010 - Soc Nuclear Med
This prospective study aimed to compare the diagnostic performance of 18 F-fluorocholine
and 18 F-FDG for detecting and staging hepatocellular carcinoma (HCC) in patients with …

Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma

…, JP Gendre, JD Grange, S Houry, JN Talbot - International Journal of …, 2005 - Elsevier
Purpose: To study the impact of fused 18 F-fluoro-deoxy-d-glucose (FDG)-hybrid positron
emission tomography (PET) and computed tomography (CT) images on conformal …

[HTML][HTML] Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: a review and position …

FE Lecouvet, JN Talbot, C Messiou, P Bourguet… - European journal of …, 2014 - Elsevier
Assessment of the response to treatment of metastases is crucial in daily oncological practice
and clinical trials. For soft tissue metastases, this is done using computed tomography (CT)…

[HTML][HTML] A pilot comparison of 18F-fluorocholine PET/CT, ultrasonography and 123I/99mTc-sestaMIBI dual-phase dual-isotope scintigraphy in the preoperative …

…, M Tassart, F Montravers, S Périé, JN Talbot - Medicine, 2015 - journals.lww.com
We compared 18 F-fluorocholine hybrid positron emission tomography/X-ray computed
tomography (FCH-PET/CT) with ultrasonography (US) and scintigraphy in patients with …

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non …

…, F Montravers, B Milleron, B Lebeau, JN Talbot - International Journal of …, 2005 - Elsevier
Purpose: To report a retrospective study concerning the impact of fused 18 F-fluoro-deoxy-d-glucose
(FDG)-hybrid positron emission tomography (PET) and CT images on three-…

PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT

JN Talbot, F Gutman, L Fartoux, JD Grange… - European journal of …, 2006 - Springer
Purpose The diagnostic accuracy of [ 18 F]fluorodeoxyglucose (FDG) PET is insufficient to
characterise hepatocellular carcinoma (HCC) in liver masses and to diagnose all cases of …

Is 18F-Fluorocholine-Positron Emission Tomography/Computerized Tomography a New Imaging Tool for Detecting Hyperfunctioning Parathyroid Glands in Primary …

…, K Kerrou, S Balogova, JN Talbot… - The Journal of …, 2014 - academic.oup.com
Context: Preoperative ultrasonography and scintigraphy using 99m Tc-sestamibi are commonly
used to localize abnormal parathyroid glands. In cases of discrepant results between …

[HTML][HTML] 18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type

S Balogova, JN Talbot, V Nataf, L Michaud… - European Journal of …, 2013 - Springer
6-Fluoro-( 18 F)-L-3,4-dihydroxyphenylalanine (FDOPA) is an amino acid analogue for
positron emission tomography (PET) imaging which has been registered since 2006 in several …